The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback